These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
861 related articles for article (PubMed ID: 19351790)
1. Epigenetic therapy using the histone deacetylase inhibitor for increasing therapeutic gain in oral cancer: prevention of radiation-induced oral mucositis and inhibition of chemical-induced oral carcinogenesis. Chung YL; Lee MY; Pui NN Carcinogenesis; 2009 Aug; 30(8):1387-97. PubMed ID: 19351790 [TBL] [Abstract][Full Text] [Related]
2. Non-viral delivery of the connexin 43 gene with histone deacetylase inhibitor to human nasopharyngeal tumor cells enhances gene expression and inhibits in vivo tumor growth. Hattori Y; Fukushima M; Maitani Y Int J Oncol; 2007 Jun; 30(6):1427-39. PubMed ID: 17487363 [TBL] [Abstract][Full Text] [Related]
3. Apoptosis and tumor remission in liver tumor xenografts by 4-phenylbutyrate. Svechnikova I; Gray SG; Kundrotiene J; Ponthan F; Kogner P; Ekström TJ Int J Oncol; 2003 Mar; 22(3):579-88. PubMed ID: 12579311 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of D-methionine as a novel oral radiation protector for prevention of mucositis. Vuyyuri SB; Hamstra DA; Khanna D; Hamilton CA; Markwart SM; Campbell KC; Sunkara P; Ross BD; Rehemtulla A Clin Cancer Res; 2008 Apr; 14(7):2161-70. PubMed ID: 18381958 [TBL] [Abstract][Full Text] [Related]
5. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications. Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893 [TBL] [Abstract][Full Text] [Related]
6. Dynamics of wound healing signaling as a potential therapeutic target for radiation-induced tissue damage. Chung YL; Pui NN Wound Repair Regen; 2015; 23(2):278-86. PubMed ID: 25682986 [TBL] [Abstract][Full Text] [Related]
7. Expression of survivin and XIAP for DMBA-induced hamster buccal pouch squamous cell carcinogenesis is associated with p53 accumulation. Hsue SS; Chen YK; Lin LM Oral Oncol; 2008 Jan; 44(1):43-9. PubMed ID: 17306609 [TBL] [Abstract][Full Text] [Related]
8. SULF1 inhibits tumor growth and potentiates the effects of histone deacetylase inhibitors in hepatocellular carcinoma. Lai JP; Yu C; Moser CD; Aderca I; Han T; Garvey TD; Murphy LM; Garrity-Park MM; Shridhar V; Adjei AA; Roberts LR Gastroenterology; 2006 Jun; 130(7):2130-44. PubMed ID: 16762634 [TBL] [Abstract][Full Text] [Related]
9. Histone deacetylase inhibitors radiosensitize human melanoma cells by suppressing DNA repair activity. Munshi A; Kurland JF; Nishikawa T; Tanaka T; Hobbs ML; Tucker SL; Ismail S; Stevens C; Meyn RE Clin Cancer Res; 2005 Jul; 11(13):4912-22. PubMed ID: 16000590 [TBL] [Abstract][Full Text] [Related]
10. Inhibitory effects of Zengshengping fractions on DMBA-induced buccal pouch carcinogenesis in hamsters. Guan XB; Sun Z; Chen XX; Wu HR; Zhang XY Chin Med J (Engl); 2012 Jan; 125(2):332-7. PubMed ID: 22340569 [TBL] [Abstract][Full Text] [Related]
11. Survivin expression is regulated by an epigenetic mechanism for DMBA-induced hamster buccal-pouch squamous-cell carcinomas. Chen YK; Hsue SS; Lin LM Arch Oral Biol; 2005 Jun; 50(6):593-8. PubMed ID: 15848153 [TBL] [Abstract][Full Text] [Related]
12. Induction of histone acetylation and growth regulation in eryrthroleukemia cells by 4-phenylbutyrate and structural analogs. Lea MA; Randolph VM; Hodge SK Anticancer Res; 1999; 19(3A):1971-6. PubMed ID: 10470142 [TBL] [Abstract][Full Text] [Related]
13. Effects of thalidomide on DMBA-induced oral carcinogenesis in hamster with respect to angiogenesis. Yang Y; Ge JP; Zhou ZT J Oral Pathol Med; 2009 May; 38(5):455-62. PubMed ID: 19141066 [TBL] [Abstract][Full Text] [Related]
14. Histone deacetylase inhibitors preferentially augment transient transgene expression in human dermal fibroblasts. Yasukawa K; Sawamura D; Goto M; Nakamura H; Shimizu H Br J Dermatol; 2007 Oct; 157(4):662-9. PubMed ID: 17711521 [TBL] [Abstract][Full Text] [Related]
15. The novel histone deacetylase inhibitor BL1521 inhibits proliferation and induces apoptosis in neuroblastoma cells. de Ruijter AJ; Kemp S; Kramer G; Meinsma RJ; Kaufmann JO; Caron HN; van Kuilenburg AB Biochem Pharmacol; 2004 Oct; 68(7):1279-88. PubMed ID: 15345317 [TBL] [Abstract][Full Text] [Related]
16. Development of histone deacetylase inhibitors for cancer treatment. Marchion D; Münster P Expert Rev Anticancer Ther; 2007 Apr; 7(4):583-98. PubMed ID: 17428177 [TBL] [Abstract][Full Text] [Related]
18. YM753, a novel histone deacetylase inhibitor, exhibits antitumor activity with selective, sustained accumulation of acetylated histones in tumors in the WiDr xenograft model. Shindoh N; Mori M; Terada Y; Oda K; Amino N; Kita A; Taniguchi M; Sohda KY; Nagai K; Sowa Y; Masuoka Y; Orita M; Sasamata M; Matsushime H; Furuichi K; Sakai T Int J Oncol; 2008 Mar; 32(3):545-55. PubMed ID: 18292931 [TBL] [Abstract][Full Text] [Related]